2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$7.06-$0.23 (-3.16%)
Price as of Oct 02, 2026 5:30 PM EDT- $1.6BMarket Cap
- -34.09%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$7.06-$0.23 (-3.16%)
OCUL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.29 | ||
Change | -$0.38 (-4.95%) | ||
Open | $7.63 | ||
High | $7.71 | ||
Low | $7.26 | ||
Previous Close | $7.67 | ||
Volume | 4,514,297 | ||
30-Day Average Volume | 3,233,791 | ||
1-Week Change | -25.76% | ||
1-Month Change | -31.03% | ||
1-Year Change | -34.09% | ||
3-Year Change | 132.17% | ||
5-Year Change | -29.70% | ||
Fundamentals | |||
Shares Outstanding | 219.6M | ||
Total Assets | $671.3M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | $13.5M | ||
Net Income | -$78.8M | ||
Free Cash Flow | -$70.6M | ||
EBIT | -$78.8M | ||
EBITDA | -$76.9M | ||
Net Working Capital | $595.3M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 80 | ||
P/B | 3 | ||
P/E | -21 | ||
PEG | -2 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue